They have revealed the hitherto unknown role of the NADPH oxidase NOX2 in immune recognition, thus shedding light on how the immune system works and so enhancing our capacity to manipulate and use it therapeutically. This discovery, published in the July 14, 2006 issue of Cell, should help us to fine-tune the immune response in the treatment of certain diseases like cancer.
The body is constantly under attack from outside forces (viruses and bacteria) and sometimes from forces within (cellular abnormalities leading to cancer). Its defensive response is to activate the immune system. There are two types of defense. First, there is innate immunity, which has no memory and so is constantly on the lookout for infectious agents to destroy. Second, there is adaptive immunity, which over time acquires memories of particular pathogens.
This requires a “learning” phase in which the dendritic cells degrade pathogenic agents into characteristic fragments, the epitopes, and then present these epitopes to the T and B lymphocytes, thereby initiating immune responses. The pathogen’s profile is memorized through this learning process and the next time the same pathogen is encountered the body immediately recognizes it and so is able to respond rapidly.
NOX2, immunity’s double agent
In innate immune responses, the invader is totally destroyed, a process in which the NADPH oxidase NOX2 plays a central role. In neutrophils, the cells at the heart of innate immune responses, NOX2 ensures the complete destruction of invading pathogens so they are no longer harmful to the body.
In adaptive immune responses, the dendritic cells’ challenge is to degrade the pathogen just partially, thus preserving sufficiently representative fragments that can be presented to the T and B lymphocytes. Ariel Savina at the Institut Curie, in the Inserm team of Sebastian Amigorena(1), has been studying how dendritic cells, the body’s “watchdogs”, achieve this controlled degradation of pathogens into epitopes. What they have found is that NOX2 is also implicated in adaptive immune responses. Its role in this case contrasts with that in neutrophils. NOX2 regulates the pH in the compartments (phagosomes) of the dendritic cells where pathogens are degraded, thus ensuring suitable acidity.
This pH regulation slows the degradation of the pathogens thus avoiding their complete destruction, which allows the dendritic cells to trigger a specific and efficient adaptive immune response.
These new findings shed light on how the immune system works and should help us to optimize one of the most promising approaches to cancer treatment: immunotherapy, in which the immune system is used to destroy tumor cells. The Institut Curie has for many years been participating actively in the development of innovative immunotherapeutic strategies. Two clinical trials are currently under way at the Institut Curie, one in patients with choroidal melanoma and another in cervical cancer patients. The results are expected some time in 2007.
(1) Sebastian Amigorena is CNRS Director of Research and Head of Inserm/Institut Curie Unit 653 “Immunity and cancer”.
Catherine Goupillon | alfa
Inactivate vaccines faster and more effectively using electron beams
23.03.2017 | Fraunhofer-Institut für Organische Elektronik, Elektronenstrahl- und Plasmatechnik FEP
Hunting pathogens at full force
22.03.2017 | Helmholtz-Zentrum für Infektionsforschung
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
23.03.2017 | Health and Medicine
23.03.2017 | Physics and Astronomy
22.03.2017 | Materials Sciences